Episode 4: Benefits of RASi Utilization

Episode 4: Benefits of RASi Utilization

Up next

Episode 34: The Rationale for Complement Inhibition in the Management of IgA Nephropathy

In Episode 34, the first in a three-part Conversations in Nephrology series on IgA nephropathy (IgAN), host Brad Rovin, MD (The Ohio State University), KDIGO IgAN/IgAV Guideline Co-Chair, is joined by Dana Rizk, MD (University of Alabama at Birmingham), to explore the rationale f ...  Show more

Episode 33: Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next

In the third episode of the KDIGO Conversations in Nephrology FSGS series, host Dr. Kirk Campbell (University of Pennsylvania) sits down with world-renowned glomerular disease expert Dr. Jai Radhakrishnan (Columbia University) to navigate the shifting landscape of Focal Segmental ...  Show more

Recommended Episodes

CKD MBD in 2025: Updates from KDIGO
Life as a Nephrology Professional

In this episode of Life as a Nephrology Professional, host, Raphy Rosen is joined once again by Thomas L. Nickolas to continue to discuss the world of CKD MBD. They explore KDIGO's update from the recent controversies conference and unpack the publication from Kidney Internationa ...  Show more

Season 4 Episode 5: PDOPPS International Study of Practice Patterns and Outcomes of Peritoneal Dialysis Patients
Global Kidney Care Podcast Provided by ISN

This latest episode of the Global Kidney Care Podcast is an effort of the ISN, ISPD, and Arbor Research Collaborative for Health (the coordinating center for the DOPPS family of studies). This episode is focused on PDOPPS, our international study of practice patterns and outcomes ...  Show more

Renal Replacement Therapies
Run the List

Dr. Staci Leisman, Associate Professor of Medicine and Medical Education at the Icahn School of Medicine at Mount Sinai, joins us to discuss renal replacement therapies. With host Dr. Emily Gutowski, she works through several cases that highlight the different types of RRT, advan ...  Show more